START FREE TRIAL

Is Microsoft Winning AI — Or Just Funding Its Rivals?

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

Microsoft continues to expand its AI footprint, but user engagement with Copilot is falling fast. Despite 15 million paid Copilot seats, recent data shows a steep decline in users selecting it as their go-to assistant.

The market sees a strong infrastructure story backed by cloud revenue momentum. But adoption metrics tell a different tale—raising new questions about the durability of Microsoft’s AI positioning.

User Adoption Vs Installed Base

Copilot’s reach spans over 450 million Microsoft 365 subscribers. Yet only a small fraction actively use it, and that share is shrinking. From July to January, primary usage preference dropped from 18.8% to 11.5%.

The gap between licenses sold and behavior observed is widening. Employees with access often default to rival tools, signaling that…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

Merck KGaA (ETR:MRK) has made a bold early move...

AI’s $3 Trillion Bill Just Arrived at the Apple Store. Here’s What Comes Next.

Your next MacBook is $200 more expensive. Your next...

The Micron Post-Mortem. The Numbers Were So Big They Don’t Look Real.

Three days ago on this page, we told you...

SpaceX: Is Elon Musk’s AI Empire Turning Into Wall Street’s Biggest Debt Test?

Twelve days after SpaceX raised $86 billion in the...

AI Trade Has Its First MAJOR CRACK as KOSPI Crashes 10%!

South Korea's stock market just had its worst day...

Related Articles

AI Trade Has Its First MAJOR CRACK as KOSPI Crashes 10%!

South Korea's stock market just had its worst day...

Alphabet: The $225 Billion AI Talent Shock Wall Street Cannot Ignore

Alphabet Inc. (NASDAQ:GOOGL) just gave Wall Street a reminder...

Micron Reports in 48 Hours. The Number Everyone Is Watching Isn’t the EPS.

Micron Technology reports earnings on Wednesday evening. The stock is...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee...
spot_img

Related Articles

Popular Categories

spot_imgspot_img